Precision AQ

We’re looking forward to the Pharmaceutical Marketing Excellence Awards in London this evening, where we’re proud to be nominated in both the Launch Excellence and Excellence in Customer Engagement and Experience categories. We’re wishing the best of luck to our talented teams and amazing client partners who made this possible! #PMEA #awards #medcomms

What an incredible week at #ISPOREurope! Our team had the opportunity to connect with peers, share innovative ideas, and engage in meaningful discussions about the future of HEOR, groundbreaking research, pricing strategies, and global access solutions. These conversations have left us inspired and energized to continue driving impactful change. Thank you, Barcelona, for an unforgettable experience - until next time!

In recognition of Alzheimer’s Awareness Month, we’re highlighting the challenges family caregivers face. Our very own Maureen Hennessey, PhD, CPCC, CPHQ, Christopher Terrone, and Kirby Child dive into the impact on caregivers’ well-being and share actionable strategies for clinicians, health plans, and pharmaceutical companies to enhance support. Discover how we can help reduce caregiver burden and improve care in PharmaLive: https://lnkd.in/ef9ZFPzw #AlzheimersAwareness #Caregiving #HealthcareSupport

What does the future hold for Medicare? SVP Andrew Cournoyer delves into the critical impacts from the election—like a staggering 26% reduction in Prescription Drug Plan offerings – and how this may effect pharma leaders in Pharmalive. With potential payer consolidations and shrinking benefits on the horizon, the choices we make now could redefine health care for millions. #2024Election #MedicareFuture #HealthcarePolicy

Ready to immerse yourself in the world of pharmaceutical marketing? In our 12-week graduate internship program, Precision University, you will: ??Experience the value Precision AQ brings to our clients ?? Develop content for a wide range of deliverables ?? Evaluate literature and coordinate references for marketing materials ?? Apply Precision AQ content development processes and best practices to your everyday work If you’re an upcoming PhD or PharmD graduate ready to jump start your career in medical writing, apply today: https://lnkd.in/eWa2Uepv

We're proud that our International Healthcare Communications team has been nominated for three Pharmaceutical Marketing Excellence Awards (PMEAs)! We cannot wait to celebrate this acheivement at the awards event on 21 November. Will you be there? Come say hi - we'd love to connect! #PMEA #medcomms #awards

ISPOR EU kicks off tomorrow—will we see you there? Our team is excited to share 18 posters, 4 issue panels, and 1 short course on some of the most pressing topics. Let’s connect. Whether at a session or over a coffee, we’d love to explore how innovative research is shaping access strategies that truly make a difference. Check out our sessions or book a meeting with our HEOR, Market Access, and Pricing experts here: https://lnkd.in/g5EpjZhX #ISPOR #ISPOREU #HEOR #marketaccess

Autologous cell and gene therapies show life-saving potential but face significant hurdles such as high costs, limited access, and payer concerns over long-term effectiveness. In the first of a four-part series for CGTLive, Molly Borchardt, Philip Cyr, and Erin Lopata discuss how companies can overcome payer challenges and empower greater patient access. Read more: https://lnkd.in/eUUaczH8 #CellTherapy #GeneTherapy #HealthcareInnovation #PatientAccess #PayerChallenges

Innovation in biotech is transforming healthcare, but are outdated technologies being phased out quickly enough? In a new PharmaLive article, our very own Philip Cyr, Ross Maclean, and Ray Roth discuss how the #pharmaindustry has a unique opportunity to drive change—eliminating low-value treatments, advancing high-value care, and improving patient access. Innovation isn’t just about new therapies—it’s about improving outcomes by retiring outdated ones. Let’s push for more efficient care! https://lnkd.in/e9xHvNSU #PharmaInnovation #HealthcareEfficiency #HealthTech

With the growing list of approved cell and gene therapies, payors and pharma are increasingly exploring alternative payment models to balance high costs and unknown long-term efficacy. In a recent article published by GenomeWeb, VP of the Access Experience team at Precision AQ, Erin Lopata, shares critical insights into how payors are absorbing these costs and the potential future impacts. Erin highlights the importance of risk-sharing models and how payors are gearing up to handle an influx of these life-changing treatments. https://lnkd.in/eDCNzRq7 #GeneTherapy #HealthcareInnovation #PrecisionAQ #AlternativePaymentModels